insiderdelta

Ultragenyx Pharmaceutical Inc.

RARECIK 0001515673 · Every Form 4 filed by insiders at this issuer.

Filings

14

Latest Mar 12, 2024

Unique insiders

10

Showing

14 of 14

Page 1

Top insiders

Most active reporters at Ultragenyx Pharmaceutical Inc.

NameRolesFilings
KAKKIS EMIL D
OfficerDirector
3
Huizenga Theodore Alan
Officer
2
Kassberg Thomas Richard
Officer
2
Crombez Eric
Officer
1
Fust Matthew K
Director
1
Harris Erik
Officer
1
Horn Howard
Officer
1
Huang Dennis Karl
Officer
1
Parschauer Karah Herdman
Officer
1
Pinion John Richard
Officer
1

All filings

14 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 12, 2024
Kassberg Thomas Richard
CBO & EVP
S11,509$49.93$574,644
Mar 11, 2024
Fust Matthew K
Director
S7,500$50.88$381,600
Mar 5, 2024
KAKKIS EMIL D
President & CEO · Director
F17,417$53.69$935,119
Mar 5, 2024
Harris Erik
EVP & Chief Commercial Officer
S4,768$53.76$256,328
Mar 5, 2024
Crombez Eric
EVP and Chief Medical Officer
S1,238$53.76$66,555
Mar 5, 2024
Huizenga Theodore Alan
SVP, Chief Accounting Officer
S341$53.76$18,332
Mar 5, 2024
Pinion John Richard
See Remarks
S4,173$53.76$224,340
Mar 5, 2024
Huang Dennis Karl
See Remarks
F470$53.69$25,234
Mar 5, 2024
Kassberg Thomas Richard
CBO & EVP
S1,011$53.76$54,351
Mar 5, 2024
Parschauer Karah Herdman
EVP and Chief Legal Officer
S3,756$53.76$201,923
Mar 5, 2024
Horn Howard
Chief Financial Officer
A19,400$0.00$0
Feb 8, 2024
KAKKIS EMIL D
President & CEO · Director
S30,000$45.00$1,350,000
Jan 2, 2024
Huizenga Theodore Alan
SVP, Chief Accounting Officer
M3,000$21.00$63,000
Jan 2, 2024
KAKKIS EMIL D
President & CEO · Director
S30,000$47.87$1,436,100

Showing 1–14 of 14

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.